[Image: Dentons logo]
Dentons Law Offices (Wuhan)
Legal Opinion on the 2026 First Extraordinary General Meeting of Wuhan Mindray Bio-Medical Electronics Co., Ltd.
To: Wuhan Mindray Bio-Medical Electronics Co., Ltd.
In accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, and the Rules for General Meetings of Shareholders of Listed Companies issued by the China Securities Regulatory Commission, Dentons Law Offices (Wuhan) was engaged by Wuhan Mindray Bio-Medical Electronics Co., Ltd. to provide legal services for the 2026 First Extraordinary General Meeting.
Our firm declares that we have only issued legal opinions regarding the convocation procedures, meeting procedures, qualifications of attendees and conveners, and voting results. We do not express opinions on the specific proposals, figures, or content discussed at the meeting.
I. Procedures for Convocation and Holding of the Meeting
(I) Convocation Procedures
The meeting was proposed and convened by the Board of Directors. On July 24, 2026, the company held the eighth meeting of the fifth Board of Directors, which approved the proposal to convene the 2026 First Extraordinary General Meeting. On July 25, 2026, the company disclosed the notice of the meeting. On August 1, 2026, the company disclosed a supplementary notice regarding additional temporary proposals, detailing the voting methods, time, location, and agenda.
(II) Meeting Procedures
The meeting was held via a combination of on-site voting and online voting. The on-site meeting took place on August 13, 2026, at 14:00 in Conference Room 203, Building 1, Wuhan Mindray Bio-Medical Electronics Industrial Park, No. 77 Jiulong Middle Road, East Lake High-tech Development Zone, Wuhan. The meeting was chaired by the Chairman of the Board. Online voting was conducted via the Shenzhen Stock Exchange trading system and internet voting system on August 13, 2026.
Our firm believes that the convocation and meeting procedures comply with relevant laws, administrative regulations, the Articles of Association, and the Rules of Procedure for Shareholders' Meetings.
II. Attendees and Convener
(I) Qualifications of Attendees
According to the Company Law, the Securities Law, the Articles of Association, and the meeting notice, attendees included:
-
Shareholders registered with the Shenzhen Branch of China Securities Depository and Clearing Corporation as of the market close on the equity registration date of August 10, 2026.
-
Directors and senior management of the company.
-
Witnessing lawyers appointed by our firm.
(II) Meeting Attendance
A total of 177 shareholders and proxies attended the meeting, representing 108,855,736 shares, or 51.8239% of the company's total voting shares.
-
On-site: 17 shareholders and proxies representing 104,752,554 shares (49.8705%).
-
Online: 160 shareholders representing 4,103,182 shares (1.9534%).
-
Small and medium investors: 174 shareholders and proxies representing 6,993,790 shares (3.3296%).
(III) Convener
The convener of the meeting was the Board of Directors. Our firm believes the qualifications of the attendees and the convener are legal and valid.